Patients scheduled for colonoscopy
Conditions
Interventions
Niflec(polyethylene glycol lavage) group 1) 10ml Laxoberon Solution is administered orally at bedtime 2) Patients are instructed to drink only clear liquids after dinner 3) At our endscopy unit, pa
Sponsors
Department of Gastroenterology, The University of Tokyo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who fills everything the following 1) Patients scheduled for colonoscopy in our hospital 2) Age of patients is from 20 to 75 years old 3) Patients who were able to provide written informed consent for participation in this study 4) Outpatient and in-patient
Exclusion criteria
Exclusion criteria: The following proceduresis excluded from the criteria 1) Patients with uncontrolled congestive heart failure, unstable angina, untreated cardiac arrhythmia, prolong QT interval, myocardial infarction, percutaneous transluminal coronary angioplasty or previous coronary artery bypass graft surgery, basic heart disease (valvular disease, cardiomyopathy, and arrhythmia, etc.) 2) Patients with the presence of ascites 3) Patients with acute bowel obstruction or pseudo-obstruction of the bowel 4) Patients with toxic megacolon 5) Patients with biopsy-proven acute phosphate nephropathy 6) Patients who is known allergy or hypersensitivity to NaP salts or PEG 7) Patients with renal insufficiency (creatinine>2.0mg/dL or BUN>25mg/dL) 8) Patients with a history of convulsive attack or Patients at higher risk of convulsive attack 9) Patients with severe chronic constipation 10) Patients with clinical symptoms caused by narrowing of colon lumen or diverticulosis of colon 11) Patients who need emergency colonoscopy 12) Patients with inflammatory bowel disease 13) Pregnant females and lactating women 14) Patients who needs endoscopic therapy (EMR, polypectomy, etc.) 15) Patients who have past history of abdominal surgery other than appendectomy 16) Patients whom examination the responsible(contributory) doctor evaluate inappropriate as study subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate detection rates of polyps smaller than 5mm | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate detection rates of all prominent lesions and diverticula To evaluate blood pressure and pulse rates of patients before and after colonoscopy | — |
Countries
Japan
Outcome results
None listed